The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
lets get 5-10 first :)
Doc - on the contrary, I stand by what I said. Go through the RNS from covid days…. I was one of the few dissenting voices. The mcap went up to £700 million at one point. In the end I was proven to be right.
Andy - don’t try to be clever now, didn’t you use to be invested here and was ramping like everyone else. Even when I mentioned that the trial design was botched by allowing vaccinated into the study. The share price was above £1 then. There is no point coming here now and voicing a negative opinion when it’s sitting almost at cash in bank.
If you had sense, you should have sold then and shorted. But you couldn’t as it dropped massively in one day :)
Everyone is an expert in hindsight.
Banbury - Short termism is the bane of this country. A perfectly viable industry will get bashed around so that environmental virtue signalling can be upheld! Whilst the big players steal a march on us with cheaper oil and gas.
Today it is Putin, what if tomorrow its China or India for that matter. We need to take care of our own energy security and not handcuff the producers, the geopolitical situation is only going to get more complicated. The Indians and Chinese have profited the most the from the War in Ukraine. The Indians are even selling refined Russian oil back to us.... utter shambles or what!
Rant over!
you might want to look at what happened to the last company he was involved in... that's the worst case scenario!!
Firstly - Relief there was no Friday 7 am RNS :)
Secondly - Makes no sense to me why they cannot state when they spudded the well.
I haven't yet Bojo, enjoying the Russian roulette buzz with O&G stocks at the moment :) Met AN over a decade or so ago when I was still in Academia (I retired very young from it ) as the whole Parsortix story was unfolding. I kept up with it for ` year or two and with all the delays, it fell off my radadr till you mentioned it back in 2020. AN is a smart guy, they sold something to ARM to plough all efforts into Parsortix, so his pedigree is not in doubt.
I have my concerns around the barriers to adoption and the high burn rate. I need to find some time and do the research on it throughly to convince myself of the investment case. The usefulness of the technology is not in doubt, but more so whether the NHS/Industry are ready to adopt it, and how far are we from it. Personalised medicine is a buzz word that gets banded about, but it requires a lot of infrastructure investment from IT connected to wide availability of sequencing technology.
NGR - yes correct, that's what it seems to suggest. The BOD was happy for the price to be inflated, only to get at the final stage and realise its too high and started to dampen the share price by giving out confusing and ambiguous messages.
Giga - I take your point as to they are dampening expectations, but this is not dampening expectations but throwing in the towel at the expense of the Shareholders. If the mcap was £20 million, this would have been a great deal for nano. But at a sustained high mcap for a loss making company, this would be a terrible deal. Unless you bought at the lows in 2019, everyone else is looking at loss. Really needs at atleast £100m net to justify current mcap.
Giga - That would be an atrocious deal for Nano. And anyone buying now would be down instantly by the rate of 50-70% minimum. This would be an utterly farcical outcome and the BOD should be fired.
Going through this board and percentages ranging from 20-50% have been banded about. 20-25% is reasonable but anything beyond that seems so absurd!
If they spent $10 million... How many multiples in just over 2.5 years would be deemed sufficient?
Going through the July 2020 Funding agreement:
"In return, the Funder can expect to receive a multiple of their invested capital in the event of a settlement or judgement in favour of Nanoco."
Anyone have any idea what they have spent on this so far?
There is always a sting in the tail with Avacta and it has large mcap already.
what other group Bojo?
so what's on the radar folks?
I can suggest OBI - John mentioned this on COPL board. Looks like an interesting play for mitigitating hospital acquired infections as well as other settings, went through the presentation and the Q&A earlier. They are starting P3 and then fast track to FDA approval. No position here yet, need to do more research.
Cizzle - Lung cancer test, Chinese partner testing it etc... small position here.
Mostly spending time on O&G these days.
Energyshares - I am not invested in AGL at least read my posts right FFS!! I was right about this company during covid times as you will remember. Anyway good luck to you, hopefully this time they will not disappoint you....
You just realised now? Somethings not been right since 2020 and their various "big ticket" collaborations that failed to achieve anything. Mind boggling that that it has mcap of over 300 million!
money sponge - do read the RNS. Its clear that they are having trouble with adoption, they spent 20 odd million for 1 million revenue, and at that rate, they will need to tap the markets again this year at some point. If you are brave enough for a trade then good on you. But for a serious investor looking to leave money in for few years, the fog on the barrier to option needs to clear somewhat, some of which may be out of their control as the ancillary infrastructure in healthcare setting may not be there yet.
if they can address barriers to adoption then all the cash raised would be worth it. But I just don't get the strategy here.... push it in research institutions or healthcare providers? A summary of where they are in both settings would be good to know.
Sangi - Illumina or other sequencing is third party downstream process and then you have the propriety set of markers for disease and or progression of it. The question is why isn’t their capture of CTC getting adopted and what are the barriers to it. They can keep chucking money at it but unless they overcome these then they will be running out of money soon enough at the rate they are going.